NASDAQ: SAVA - Cassava Sciences, Inc.

Lønnsomhet i seks måneder: -70.43%
Sektor: Healthcare

Kampanjeplan Cassava Sciences, Inc.


Om selskapet

Cassava Sciences, Inc., биотехнологическая компания, работающая на клинической стадии, разрабатывает лекарства от расстройств нервной системы. Ведущим кандидатом в терапевтический продукт является низкомолекулярный препарат PTI-125, клинические испытания которого завершены в фазе 2b; Кандидат в исследуемый диагностический продукт - это SavaDx, биомаркер крови для диагностики болезни Альцгеймера. Компания ранее называлась Pain Therapeutics, Inc. и сменила название на Cassava Sciences, Inc. в марте 2019 года. Cassava Sciences, Inc. была основана в 1998 году и базируется в Остине, штат Техас.

flere detaljer

IPO date 2000-07-14
ISIN US14817C1071
Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Дивиденд ао 5.25
Сайт https://www.cassavasciences.com
Цена ао 2.83
Prisendring per dag: 0% (2.83)
Prisendring per uke: -3.74% (2.94)
Prisendring per måned: +1.43% (2.79)
Prisendring over 3 måneder: -89.71% (27.5)
Prisendring over seks måneder: -70.43% (9.57)
Prisendring per år: -89.21% (26.24)
Prisendring over 3 år: -93.75% (45.29)
Prisendring over 5 år: -48.17% (5.46)
Prisendring over 10 år: +45.13% (1.95)
Prisendring siden begynnelsen av året: +20.94% (2.34)

Undervurdering

Navn Betydning Karakter
P/S -707555.2 0
P/BV 7.3 1
P/E 0 0
EV/EBITDA -8.45 0
Total: 2.25

Effektivitet

Navn Betydning Karakter
ROA, % -64.1 0
ROE, % -70.72 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0.5 5
Total: 0.7143

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.0013 10
Total: 9.6

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 0 0
Lønnsomhet Ebitda, % 1813.74 10
Lønnsomhet EPS, % 850.96 10
Total: 8

Transaksjonsdato Avsløringsdato Insider Type Pris Volum Mengde Del opp til, % Del etterpå, % Dokument
29.03.2022 29.03.2022 GUSSIN ROBERT Z
Director
Kjøpe 21.53 160 829 7470 0 0.02 link

ETF Dele, % Lønnsomhet for året, % Utbytte, %
SPDR S&P Pharmaceuticals ETF 3.0256 29.8 1.29889
iShares Neuroscience and Healthcare ETF 2.35377 19.72 0.03
Direxion Daily Pharmaceutical & Medical Bull 3X Shares 2.13161 86.72 1.2989
Virtus LifeSci Biotech Clinical Trials ETF 1.1858 63.04 0.33
iShares U.S. Pharmaceuticals ETF 0.51917 1.88 1.97922
Nuveen ESG Small-Cap ETF 0.14128 9.56 1.41019
Vanguard Russell 2000 Growth ETF 0.09 17.39 0.60264
iShares Russell 2000 Growth ETF 0.08992 38.04 0.6026
JPMorgan BetaBuilders U.S. Small Cap Equity Fund 0.07838 24.75 1.59225
iShares ESG Aware MSCI USA Small-Cap ETF 0.04799 12.78 1.49366
Vanguard Russell 2000 ETF 0.04 14.37 1.48801
Schwab U.S. Small-Cap ETF 0.03411 13.35 1.51433
iShares Morningstar Small-Cap Growth ETF 0.03395 33.63 0.72598
iShares Morningstar Small-Cap Growth ETF 0.03395 590.83 0.72598
iShares Morningstar Small-Cap ETF 0.02898 30.1 1.60498
iShares Morningstar Small-Cap ETF 0.02898 391.25 1.60498
ProShares UltraPro Russell2000 0.02613 89.82 1.47873
iShares Morningstar Small Cap Value ETF 0.02411 26.7 2.50476
iShares Morningstar Small-Cap Value ETF 0.02411 199.14 2.50476
Fidelity MSCI Health Care Index ETF 0.01949 0.1657 1.46057
ProShares Hedge Replication ETF 0.0075 5.92 1.47892
Humankind US Stock ETF 0.00462 18.81 1.99919
FlexShares Morningstar US Market Factor Tilt Index Fund 0.00343 20.03 1.69572
Schwab U.S. Broad Market ETF 0.00204 23.7 1.43354
iShares Russell 3000 ETF 0.00201 23.61 1.43482
SPDR Portfolio MSCI Global Stock Market ETF 0.00114 15.66 2.19607
Vanguard ESG U.S. Stock ETF 0 23.74 1.26927
Vanguard Russell 3000 ETF 0 31.87 1.43817



Veileder Stillingstittel Betaling Fødselsår
Mr. Eric J. Schoen Chief Financial Officer 460k 1968 (57 år)
Mr. Michael Zamloot Senior Vice President of Technical Operations N/A
Dr. Lindsay H. Burns Ph.D. Senior Vice President of Neuroscience N/A
Dr. James W. Kupiec M.D. Chief Medical Officer 435k 1953 (72 år)
Mr. R. Christopher Cook Senior VP, Company Secretary & General Counsel 425k 1964 (61 år)
Dr. Michael Marsman Pharm.D. Senior Vice President of Regulatory Affairs N/A
Dr. George Thornton Ph.D. Senior Vice President of Technology N/A
Mr. Richard Jon Barry CEO & Director 1959 (66 år)

Adresse: United States, Austin, TX , 7801 North Capital of Texas Highway - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.cassavasciences.com